» Articles » PMID: 20425038

Management of Low-grade Glioma

Overview
Specialty Neurology
Date 2010 Apr 29
PMID 20425038
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The optimal management of patients with low-grade glioma (LGG) is controversial. The controversy largely stems from the lack of well-designed clinical trials with adequate follow-up to account for the relatively long progression-free survival and overall survival of patients with LGG. Nonetheless, the literature increasingly suggests that expectant management is no longer optimal. Rather, there is mounting evidence supporting active management including consideration of surgical resection, radiotherapy, chemotherapy, molecular and histopathologic characterization, and use of modern imaging techniques for monitoring and prognostication. In particular, there is growing evidence favoring extensive surgical resection and increasing interest in the role of chemotherapy (especially temozolomide) in the management of these tumors. In this review, we critically analyze emerging trends in the literature with respect to management of LGG, with particular emphasis on reports published during the past year.

Citing Articles

Incidental brain tumor findings in children: prevalence, natural history, management, controversies, challenges, and dilemmas.

Soleman J, Constantini S, Roth J Childs Nerv Syst. 2024; 40(10):3179-3187.

PMID: 39215810 PMC: 11511734. DOI: 10.1007/s00381-024-06598-z.


Glutathione metabolism-related gene signature predicts prognosis and treatment response in low-grade glioma.

Deng Z, Luo J, Ma J, Jin Y, Yu Y Aging (Albany NY). 2024; 16(11):9518-9546.

PMID: 38819225 PMC: 11210255. DOI: 10.18632/aging.205881.


An effective ensemble learning approach for classification of glioma grades based on novel MRI features.

Hassan M, Al-Zurfi A, Abed M, Ahmed K Sci Rep. 2024; 14(1):11977.

PMID: 38796531 PMC: 11128012. DOI: 10.1038/s41598-024-61444-1.


SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).

Vaz-Salgado M, Garcia B, Perez I, Munarriz B, Domarco P, Gonzalez A Clin Transl Oncol. 2024; 26(11):2856-2865.

PMID: 38662171 PMC: 11467015. DOI: 10.1007/s12094-024-03456-x.


Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies.

Toader C, Eva L, Costea D, Corlatescu A, Covache-Busuioc R, Bratu B Brain Sci. 2023; 13(12).

PMID: 38137148 PMC: 10741942. DOI: 10.3390/brainsci13121700.


References
1.
Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F . Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J Neurooncol. 2009; 97(1):73-80. DOI: 10.1007/s11060-009-9991-4. View

2.
Baumert B, Stupp R . Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy. Ann Oncol. 2008; 19 Suppl 7:vii217-22. DOI: 10.1093/annonc/mdn434. View

3.
Talos I, Zou K, Ohno-Machado L, Bhagwat J, Kikinis R, Black P . Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology. 2006; 239(2):506-13. PMC: 1475754. DOI: 10.1148/radiol.2392050661. View

4.
Jackson R, Fuller G, Abi-Said D, Lang F, Gokaslan Z, Shi W . Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001; 3(3):193-200. PMC: 1920616. DOI: 10.1093/neuonc/3.3.193. View

5.
Claus E, Black P . Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer. 2006; 106(6):1358-63. DOI: 10.1002/cncr.21733. View